Direct-to-consumer advertising of prescription drugs - do benefits outweigh harm ?
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Presentation
- By: MINTZES, Barbara (University of British Columbia, Centre for Health Services & Policy Res., Vancouver, B.c., Canada)
Background: Direct-to-consumer advertising (DTCA) is legal in two industrialized countries, the United States and New Zealand, and spending has grown dramatically during the last decade. In the European Union, Canada, Australia and Japan, DTCA is prohibited as part of the protection offered by prescription-only status. Those proposing broader.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.